Yes Phil we are making something more profound than widgets. Great results for Pembro+ EFTI in the PD-L1(low) patients, and a general benefit (ORR) for all patients. Message to Fredrick and team - just keep doing what you have been doing - "keep your head down and bum up" because its gunna make a difference to peoples lives.
- Forums
- ASX - By Stock
- IMM
- Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial
Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial, page-37
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
32.3¢ |
Change
-0.003(0.77%) |
Mkt cap ! $473.0M |
Open | High | Low | Value | Volume |
32.5¢ | 32.8¢ | 32.0¢ | $122.7K | 378.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
57 | 1166305 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 328271 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
58 | 1167260 | 0.320 |
18 | 144433 | 0.315 |
19 | 123280 | 0.310 |
9 | 191500 | 0.305 |
17 | 904927 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 379086 | 22 |
0.330 | 230222 | 14 |
0.335 | 701563 | 11 |
0.340 | 128999 | 7 |
0.345 | 242800 | 6 |
Last trade - 14.45pm 13/02/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
AII
ALMONTY INDUSTRIES INC.
Matthias Greiffenberger, Analyst, GBC Investment Research
Matthias Greiffenberger
Analyst, GBC Investment Research
Previous Video
Next Video
SPONSORED BY The Market Online